Giapreza
- Product NDC
- 68547-005
- 11-digit product format
- 685470005
- Labeler code
- 68547
- Product ID
- 68547-005_49438c9b-3fce-4f3b-b878-18a17bc62b2e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- angiotensin II
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- La Jolla Pharmaceutical Company
- Application
- NDA209360
- Marketing category
- NDA
- Marketing start
- 2022-09-15
- Substance
- ANGIOTENSIN II
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Vasoconstriction [PE], Vasoconstrictor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Giapreza
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ANGIOTENSIN II | .5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | M089EFU921 |
| Rxcui | 1999007, 1999012, 2611704, 2611707 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68547-005-01 | Giapreza | 1 in 1 CARTON | INJECTION | 1 | | 17 |
| 68547-005-01 | Giapreza | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | | 17 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68547-005 | GIAPREZA (ANGIOTENSIN II) INJECTION [LA JOLLA PHARMACEUTICAL COMPANY] | 17 | Current NDC, Legacy NDC, 2 package rows | 20241127_c265d69a-3efe-4107-9a9e-e6fd3d531c48.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68547-005-01 | 68547000501 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68547-005-01) / 1 mL in 1 VIAL, SINGLE-DOSE | 2022-09-15 | 0000-00-00 | No | No | Current |